Nomen:PRL-8-53
Nomen chemicum:Methyl 3-(2-(benzyl(yl)amino)ethyl)benzoate
Synonyma:PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;3-(2-Benzyl(yl)aminoethyl)acidum benzoicum yl hydrochloridum niensis;m-[2-(Benzylmethylamino)ethyl]acidum benzoicum yl hydrochloridum niensis;Acidum benzoicum, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride
CAS 51352-87-5
MF:C18H22ClNO2
MW 319.82578
Dosis: Subditi in iudiciis humanis donati sunt 100 mg dies non videntur aliqua negativa effectus
PRL-8-53 (eget nomen Methyl 3-(2-(benzyl(yl)amino)ethyl)benzoate) Est synthetica nootropic compositis inventa in 1972 et patented in 1975 per nuper Dr. Nicolaus Hansl, neuropharmacologist apud Creighton University in Omaha, Nebraska. Experimenta praevia animalis significaverunt compositum tum tutum et signanter nootropicum fuisse, talpas boosting doctrina in fuga non adversa effectus.
Sed cura reali in PRL-8-53 excitata est a 1978 studere in homine volunteers, quod ostendit unum doses compositi verbi retentionis ustulo plusquam emendare potuisse 200%.
PRL-8-53 Non bene intelleguntur machinationes agendi, sed vulgo creditur moderari productionem cerebri et responsionem pluribus crucialibus neurotransmittentibus. In his relationibus de studiis humanis et animalibus Hansl significavit potentiates PRL-8-53 dopamine, ex parte restringit productio serotonin, et auget cerebrum responsionem acetylcholine.
Etiamsi Hansl investigationis fama in 1978 humano studio suggerit illae actiones, mechanismum actionis non clare delineat. Quod vetustiores subditi maxime nootropicum beneficium viderint quo medicamento adiuvat conceptum dopaminis modulationis in effectibus PLR-8-53 maiorem obtinet locum.. Up-regulando normalem aetatem actis diminutionem dopaminis productionis quae cum declinatione cognitiva coniungitur notabilem habere positivum ictum in doctrina et memoria..
| Items analysi |
Specification |
Proventus |
| Aspectus |
Off solidum album pulveris |
Conformare |
| Lepidium sativum |
Conformare cum NMR |
Conforms |
| Liquefactio Point |
149-152C |
150-151C |
| Damnum in Siccatio |
≤0.50% |
0.23% |
| Requiesce in ignitio |
≤1.0% |
0.28% |
| Puritas(HPLC) |
≥99% |
99.66% |
| Metalla gravis |
NMT 20PPM |
Conforms |
| conclusio |
secundum quid |
